A comparison of two different methods of topical Anaesthesia for intravenous cannula insertion - CoolSense® (a product that cools and numbs the skin) versus EMLA® (a cream that numbs the skin).
Not yet recruiting
- Conditions
- Pain
- Registration Number
- ACTRN12618001354279
- Lead Sponsor
- Christchurch Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 63
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the analgesic effects of CoolSense® and EMLA® in intravenous cannula insertion?
How does the efficacy of CoolSense® compare to standard-of-care topical anesthetics like EMLA® in reducing procedural pain?
Are there specific biomarkers that predict patient response to either CoolSense® or EMLA® for local anesthesia?
What are the potential adverse events associated with CoolSense® versus EMLA® in clinical settings?
What are the advantages and disadvantages of using CoolSense® over EMLA® in pediatric or geriatric populations for IV cannulation?